Authors:
von Mehren, M
Arlen, P
Gulley, J
Rogatko, A
Cooper, HS
Meropol, NJ
Alpaugh, RK
Davey, M
McLaughlin, S
Beard, MT
Tsang, KY
Schlom, J
Weiner, LM
Citation: M. Von Mehren et al., The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma, CLIN CANC R, 7(5), 2001, pp. 1181-1191
Authors:
Figg, WD
Arlen, P
Gulley, J
Fernandez, P
Noone, M
Fedenko, K
Hamilton, M
Parker, C
Kruger, EA
Pluda, J
Dahut, WL
Citation: Wd. Figg et al., A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancer, SEMIN ONCOL, 28(4), 2001, pp. 62-66
Authors:
Zhu, MZ
Terasawa, H
Gulley, J
Panicali, D
Arlen, P
Schlom, J
Tsang, KY
Citation: Mz. Zhu et al., Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells, CANCER RES, 61(9), 2001, pp. 3725-3734
Authors:
Tsang, KY
Zhu, MZ
Even, J
Gulley, J
Arlen, P
Schlom, J
Citation: Ky. Tsang et al., The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activationof antigen-specific cytolytic T cells, CANCER RES, 61(20), 2001, pp. 7568-7576
Authors:
von Mehren, M
Arlen, P
Tsang, KY
Rogatko, A
Meropol, N
Cooper, HS
Davey, M
McLaughlin, S
Schlom, J
Weiner, LM
Citation: M. Von Mehren et al., Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas, CLIN CANC R, 6(6), 2000, pp. 2219-2228
Authors:
Eder, JP
Kantoff, PW
Roper, K
Xu, GX
Bubley, GJ
Boyden, J
Gritz, L
Mazzara, G
Oh, WK
Arlen, P
Tsang, KY
Panicali, D
Schlom, J
Kufe, DW
Citation: Jp. Eder et al., A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer, CLIN CANC R, 6(5), 2000, pp. 1632-1638
Authors:
Marshall, JL
Hoyer, RJ
Toomey, MA
Faraguna, K
Chang, P
Richmond, E
Pedicano, JE
Gehan, E
Peck, RA
Arlen, P
Tsang, KY
Schlom, J
Citation: Jl. Marshall et al., Phase I study in advanced cancer patients of a diversified prime-and-boostvaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses, J CL ONCOL, 18(23), 2000, pp. 3964-3973
Authors:
Arlen, P
Tsang, KY
Marshall, JL
Chen, A
Steinberg, SM
Poole, D
Hand, PH
Schlom, J
Hamilton, JM
Citation: P. Arlen et al., The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines, CANCER IMMU, 49(10), 2000, pp. 517-529